Call Number (LC) Title Results
HD9666.5 .S38 The expected return from pharmaceutical research : sources of new drugs and the profitability of R & D investment / 1
HD9666.5 .S385 1997 Pharmaceutical economics and policy / 1
HD9666.5 .S385 2007 Pharmaceutical economics and policy / 1
HD9666.5 .S385 2007eb Pharmaceutical economics and policy / 1
HD9666.5 .S658 2013eb Principles of pharmaceutical marketing / 1
HD9666.5 .S79 1983 Competition in the pharmaceutical industry : the declining profitability of drug innovation / 1
HD9666.5 .W43 2006 Profits before people? : ethical standards and the marketing of prescription drugs / 2
HD9666.5 .W43 2006eb Profits before People?. 1
HD9666.56 .K55 Marketing prescription drugs / 1
HD9666.56 .P45 The pharmaceutical industry : economics, performance, and government regulation / 1
HD9666.6 .A53 Defense procurement of foreign-made drugs : Military Operations Subcommittee staff memorandum, with Federal agency and other commentary. 1
HD9666.6 .C25 Drugs on the market : the impact of public policy on the retail market for prescription drugs / 1
HD9666.6 .E67 2006 Overdose : how excessive government regulation stifles pharmaceutical innovation / 1
HD9666.6 .G7 Drug regulation and innovation : empirical evidence and policy options / 1
HD9666.6 .H3 The real voice. 1
HD9666.6 .M55 The therapeutic nightmare : a report on the roles of the United States Food and Drug Administration, the American Medical Association, pharmaceutical manufacturers, and others in connection with the irrational and massive use of prescription drugs that may be worthless, injurious, or even lethal.
The therapeutic nightmare; a report on the roles of the United States Food and Drug Administration, the American Medical Association, pharmaceutical manufacturers, and others in connection with the irrational and massive use of prescription drugs that may be worthless, injurious,
2
HD9666.6 .M55 1967 By prescription only : a report on the roles of the United States Food and Drug Administration, the American Medical Association, pharmaceutical manufacturers, and others in connection with the irrational and massive use of prescription drugs that may be worthless, injurious, or even lethal. 1
HD9666.6 .P44 The American connection ; profiteering and politicking in the "ethical" drug industry.
The American connection : profiteering and politicking in the "ethical" drug industry.
2
HD9666.6 .P83 2005eb The public financing of pharmaceuticals : an economic approach / 1
HD9666.6 .Q7 Drug regulation and innovation : empirical evidence and policy options / 1